Lp(a): The Blood Test Most Cholesterol Panels Skip — and Why It Matters After 40
Share
Lipoprotein(a) — written Lp(a) — is a blood particle that most standard cholesterol panels don't test for. More than 90% of your Lp(a) level is set by your genetics at birth and does not meaningfully change with diet or exercise. Elevated Lp(a) raises cardiovascular risk independently of your other lipid numbers. To find out your level, ask your doctor specifically for an Lp(a) test — it is not included in a standard lipid panel.
For informational purposes only — not medical advice. Do not change your diet, exercise, or health routine without first consulting your licensed healthcare professional.
For informational purposes only — not medical advice. Do not change your diet, exercise, or health routine without first consulting your licensed healthcare professional.
For informational purposes only — not medical advice. Do not change your diet, exercise, or health routine without first consulting your licensed healthcare professional.
For informational purposes only — not medical advice. Do not change your diet, exercise, or health routine without first consulting your licensed healthcare professional.
You went to your annual checkup, got the standard bloodwork, and everything came back fine. LDL: good. HDL: solid. Triglycerides: in range. Your doctor nodded, said the numbers looked healthy, and that was that. You left feeling like you'd passed a test.
But there is a good chance the lab skipped the one number that your diet cannot fix, your workout routine cannot move, and your genetic code set before you were born. You could spend a year eating perfectly and that number would not shift by a single point.
It is called lipoprotein(a) — abbreviated Lp(a), pronounced "lipoprotein little a." Roughly one in five adults carries a level high enough to matter. Most have no idea.
What Lp(a) Actually Is — and What Makes It Different
Start with a bit of background. A lipoprotein is a particle that shuttles fat and cholesterol through your bloodstream. LDL — the "bad cholesterol" you have heard about your whole adult life — is the most familiar version. Lp(a) is its structural near-twin: almost identical, except for one extra protein bolted onto it called apolipoprotein(a), or apo(a).
That single addition changes everything about how it behaves. Lp(a) is stickier than LDL, appears to interfere with normal clot-clearing processes in the bloodstream, and is more strongly associated with the gradual accumulation of plaque in artery walls over time (PMID: 37506332). Think of LDL as the loud guest everyone talks about at the party — and Lp(a) as the quiet one in the corner who has been causing trouble all evening without anyone noticing.
This is not a fringe idea. A widely cited 2010 analysis established that elevated Lp(a) raises cardiovascular risk through a mechanism that operates on its own, separate from other blood lipid markers you regularly track (PMID: 20965889). A 2022 European consensus of cardiovascular researchers concluded that high Lp(a) carries meaningful implications for long-term heart and aortic valve health, and recommended testing at least once in every adult's lifetime. The scientific case has been building for decades; the clinical testing just has not caught up.
The Part That Surprises Almost Everyone
Here is where Lp(a) breaks every rule most people think they know about cholesterol.
LDL responds to how you live. Improve your diet, shed some weight, exercise consistently, and the number tends to fall. Statins work reliably to reduce it. The familiar story — make better choices and the number follows — applies.
Lp(a) does not follow that script at all. Research shows that more than 90% of your Lp(a) level is determined by the genetic variants you inherited, fixed essentially for life (PMID: 37506332). Dietary interventions, exercise protocols, and most cardiovascular medications — including statins — do not meaningfully move it. Some statin regimens may nudge it slightly higher, though the clinical weight of that finding is still being studied.
The implication is significant: if your Lp(a) is elevated, it is not a consequence of anything you did or did not do. The kale tried. The kale failed. But this is actually clarifying information, not just bad news. Once you understand it, the whole strategy shifts — from "lower this number" to "understand what it means and build the strongest possible cardiovascular foundation around it."
Who Has Elevated Lp(a), and How Common Is It?
IMAGE_1
You went to your annual checkup, got the standard bloodwork, and everything came back fine. LDL: good. HDL: solid. Triglycerides: in range. Your doctor nodded, said the numbers looked healthy, and that was that. You left feeling like you'd passed a test.
But there is a good chance the lab skipped the one number that your diet cannot fix, your workout routine cannot move, and your genetic code set before you were born. You could spend a year eating perfectly and that number would not shift by a single point.
It is called lipoprotein(a) — abbreviated Lp(a), pronounced "lipoprotein little a." Roughly one in five adults carries a level high enough to matter. Most have no idea.
What Lp(a) Actually Is — and What Makes It Different
Start with a bit of background. A lipoprotein is a particle that shuttles fat and cholesterol through your bloodstream. LDL — the "bad cholesterol" you have heard about your whole adult life — is the most familiar version. Lp(a) is its structural near-twin: almost identical, except for one extra protein bolted onto it called apolipoprotein(a), or apo(a).
That single addition changes everything about how it behaves. Lp(a) is stickier than LDL, appears to interfere with normal clot-clearing processes in the bloodstream, and is more strongly associated with the gradual accumulation of plaque in artery walls over time (PMID: 37506332). Think of LDL as the loud guest everyone talks about at the party — and Lp(a) as the quiet one in the corner who has been causing trouble all evening without anyone noticing.
This is not a fringe idea. A widely cited 2010 analysis established that elevated Lp(a) raises cardiovascular risk through a mechanism that operates on its own, separate from other blood lipid markers you regularly track (PMID: 20965889). A 2022 European consensus of cardiovascular researchers concluded that high Lp(a) carries meaningful implications for long-term heart and aortic valve health, and recommended testing at least once in every adult's lifetime. The scientific case has been building for decades; the clinical testing just has not caught up.
The Part That Surprises Almost Everyone
Here is where Lp(a) breaks every rule most people think they know about cholesterol.
LDL responds to how you live. Improve your diet, shed some weight, exercise consistently, and the number tends to fall. Statins work reliably to reduce it. The familiar story — make better choices and the number follows — applies.
Lp(a) does not follow that script at all. Research shows that more than 90% of your Lp(a) level is determined by the genetic variants you inherited, fixed essentially for life (PMID: 37506332). Dietary interventions, exercise protocols, and most cardiovascular medications — including statins — do not meaningfully move it. Some statin regimens may nudge it slightly higher, though the clinical weight of that finding is still being studied.
The implication is significant: if your Lp(a) is elevated, it is not a consequence of anything you did or did not do. The kale tried. The kale failed. But this is actually clarifying information, not just bad news. Once you understand it, the whole strategy shifts — from "lower this number" to "understand what it means and build the strongest possible cardiovascular foundation around it."
IMAGE_2
Who Has Elevated Lp(a), and How Common Is It?
Approximately one in five adults worldwide carries Lp(a) above the threshold researchers consider elevated — generally defined as above 50 mg/dL or 125 nmol/L (PMID: 37506332). That figure holds roughly across populations, though a large 2024 analysis found meaningful variation by ancestry: populations of African descent tend to carry higher average levels, while East Asian and many Northern European groups tend to carry lower ones (PMID: 39278229).
The bottom line: about one in five of the people reading this have a number worth knowing, and the vast majority have never been tested.
Reading the Numbers
If you get tested, here is the rough map cardiologists use:
30–50 mg/dL — borderline; worth factoring into your overall cardiovascular picture.
Above 50 mg/dL (approximately 125 nmol/L) — elevated; a conversation to have with your doctor.
A practical note: labs report Lp(a) in two different units — mg/dL and nmol/L — and they do not convert neatly from one to the other. Always confirm which unit your results are expressed in. Most cardiologists now prefer nmol/L for greater precision.
One finding worth sitting with: a 2024 study tracking women's cardiovascular health over thirty years found that elevated Lp(a) contributed to long-term risk independently of both LDL levels and markers of chronic inflammation (PMID: 39216091). A standard lipid panel, the kind most of us get every year, would catch neither your Lp(a) nor this secondary layer of risk.
What You Can Actually Do
Here is the straightforward version — no false promises, no unnecessary alarm.
Accept that lifestyle has less leverage here. Because Lp(a) is largely genetic, the familiar playbook of diet-and-exercise fixes doesn't apply to this particular number. That does not make those habits unimportant; it changes what their job is. The goal becomes supporting the strongest possible cardiovascular environment around a variable you cannot fully control.*
Get the test first. Ask your doctor to include Lp(a) in your next blood draw. It is a standard laboratory test, widely available — it simply is not part of the default lipid panel. You have to request it by name. One extra sentence to your doctor; real information in return.
Support your cardiovascular health across multiple fronts. A few evidence-backed inputs help the broader picture:*
Omega-3 fatty acids (fish oil): EPA and DHA support a healthy inflammatory environment in the vascular system.* Fish oil will not directly change your Lp(a), but supporting cardiovascular wellness more broadly remains worthwhile (PMID: 33445534).
Niacin (vitamin B3): Long studied for the role it plays in how the body handles blood fats, niacin supports that process running smoothly.* It is also a precursor in your body's production of NAD+, connecting it to broader cellular energy chemistry (https://doi.org/10.1194/jlr.s092007).
NAD+ support: NAD+ is a coenzyme that cells depend on for energy production and normal maintenance processes. Levels decline with age, and supporting your body's NAD+ is associated with healthy aging and normal vascular function.
Consistent cardiovascular exercise: Cardio will not move your Lp(a), but it remains among the most robustly validated tools available for overall heart health and metabolic resilience.*
Work with a cardiologist if your level is high. This is a fast-moving field — RNA-based therapies specifically designed to reduce Lp(a) are currently in late-stage clinical trials, and the early results look genuinely promising. A cardiologist can put your Lp(a) reading in the context of your complete risk profile and tell you whether any of those emerging options make sense for your situation today.
Last reviewed: July 2026
Last reviewed: July 2026
IMAGE_1
You went to your annual checkup, got the standard bloodwork, and everything came back fine. LDL: good. HDL: solid. Triglycerides: in range. Your doctor nodded, said the numbers looked healthy, and that was that. You left feeling like you'd passed a test.
But there is a good chance the lab skipped the one number that your diet cannot fix, your workout routine cannot move, and your genetic code set before you were born. You could spend a year eating perfectly and that number would not shift by a single point.
It is called lipoprotein(a) — abbreviated Lp(a), pronounced "lipoprotein little a." Roughly one in five adults carries a level high enough to matter. Most have no idea.
What Lp(a) Actually Is — and What Makes It Different
Start with a bit of background. A lipoprotein is a particle that shuttles fat and cholesterol through your bloodstream. LDL — the "bad cholesterol" you have heard about your whole adult life — is the most familiar version. Lp(a) is its structural near-twin: almost identical, except for one extra protein bolted onto it called apolipoprotein(a), or apo(a).
That single addition changes everything about how it behaves. Lp(a) is stickier than LDL, appears to interfere with normal clot-clearing processes in the bloodstream, and is more strongly associated with the gradual accumulation of plaque in artery walls over time (PMID: 37506332). Think of LDL as the loud guest everyone talks about at the party — and Lp(a) as the quiet one in the corner who has been causing trouble all evening without anyone noticing.
This is not a fringe idea. A widely cited 2010 analysis established that elevated Lp(a) raises cardiovascular risk through a mechanism that operates on its own, separate from other blood lipid markers you regularly track (PMID: 20965889). A 2022 European consensus of cardiovascular researchers concluded that high Lp(a) carries meaningful implications for long-term heart and aortic valve health, and recommended testing at least once in every adult's lifetime. The scientific case has been building for decades; the clinical testing just has not caught up.
The Part That Surprises Almost Everyone
Here is where Lp(a) breaks every rule most people think they know about cholesterol.
LDL responds to how you live. Improve your diet, shed some weight, exercise consistently, and the number tends to fall. Statins work reliably to reduce it. The familiar story — make better choices and the number follows — applies.
Lp(a) does not follow that script at all. Research shows that more than 90% of your Lp(a) level is determined by the genetic variants you inherited, fixed essentially for life (PMID: 37506332). Dietary interventions, exercise protocols, and most cardiovascular medications — including statins — do not meaningfully move it. Some statin regimens may nudge it slightly higher, though the clinical weight of that finding is still being studied.
The implication is significant: if your Lp(a) is elevated, it is not a consequence of anything you did or did not do. The kale tried. The kale failed. But this is actually clarifying information, not just bad news. Once you understand it, the whole strategy shifts — from "lower this number" to "understand what it means and build the strongest possible cardiovascular foundation around it."
IMAGE_2
Who Has Elevated Lp(a), and How Common Is It?
Approximately one in five adults worldwide carries Lp(a) above the threshold researchers consider elevated — generally defined as above 50 mg/dL or 125 nmol/L (PMID: 37506332). That figure holds roughly across populations, though a large 2024 analysis found meaningful variation by ancestry: populations of African descent tend to carry higher average levels, while East Asian and many Northern European groups tend to carry lower ones (PMID: 39278229).
The bottom line: about one in five of the people reading this have a number worth knowing, and the vast majority have never been tested.
Reading the Numbers
If you get tested, here is the rough map cardiologists use:
30–50 mg/dL — borderline; worth factoring into your overall cardiovascular picture.
Above 50 mg/dL (approximately 125 nmol/L) — elevated; a conversation to have with your doctor.
A practical note: labs report Lp(a) in two different units — mg/dL and nmol/L — and they do not convert neatly from one to the other. Always confirm which unit your results are expressed in. Most cardiologists now prefer nmol/L for greater precision.
One finding worth sitting with: a 2024 study tracking women's cardiovascular health over thirty years found that elevated Lp(a) contributed to long-term risk independently of both LDL levels and markers of chronic inflammation (PMID: 39216091). A standard lipid panel, the kind most of us get every year, would catch neither your Lp(a) nor this secondary layer of risk.
What You Can Actually Do
Here is the straightforward version — no false promises, no unnecessary alarm.
Accept that lifestyle has less leverage here. Because Lp(a) is largely genetic, the familiar playbook of diet-and-exercise fixes doesn't apply to this particular number. That does not make those habits unimportant; it changes what their job is. The goal becomes supporting the strongest possible cardiovascular environment around a variable you cannot fully control.*
Get the test first. Ask your doctor to include Lp(a) in your next blood draw. It is a standard laboratory test, widely available — it simply is not part of the default lipid panel. You have to request it by name. One extra sentence to your doctor; real information in return.
Support your cardiovascular health across multiple fronts. A few evidence-backed inputs help the broader picture:*
Omega-3 fatty acids (fish oil): EPA and DHA support a healthy inflammatory environment in the vascular system.* Fish oil will not directly change your Lp(a), but supporting cardiovascular wellness more broadly remains worthwhile (PMID: 33445534).
Niacin (vitamin B3): Long studied for the role it plays in how the body handles blood fats, niacin supports that process running smoothly.* It is also a precursor in your body's production of NAD+, connecting it to broader cellular energy chemistry (https://doi.org/10.1194/jlr.s092007).
NAD+ support: NAD+ is a coenzyme that cells depend on for energy production and normal maintenance processes. Levels decline with age, and supporting your body's NAD+ is associated with healthy aging and normal vascular function.
Consistent cardiovascular exercise: Cardio will not move your Lp(a), but it remains among the most robustly validated tools available for overall heart health and metabolic resilience.*
IMAGE_3
Work with a cardiologist if your level is high. This is a fast-moving field — RNA-based therapies specifically designed to reduce Lp(a) are currently in late-stage clinical trials, and the early results look genuinely promising. A cardiologist can put your Lp(a) reading in the context of your complete risk profile and tell you whether any of those emerging options make sense for your situation today.
Why Isn't This Already a Standard Test?
Inertia, mostly. The standard lipid panel — total cholesterol, LDL, HDL, triglycerides — was assembled decades ago when Lp(a) was not yet well understood. Once a test set becomes "routine," the standard is remarkably slow to expand, even as the underlying science matures.
The science has indeed matured substantially. Major cardiology societies, including the American Heart Association and the European Atherosclerosis Society, now recommend measuring Lp(a) at least once in adulthood — and more frequently when heart disease runs in the family. Guidelines trail the evidence. Knowing to ask puts you ahead of the gap.
FAQ
What does Lp(a) stand for?
Lipoprotein(a). The "(a)" refers to apolipoprotein(a), the extra protein that sets it apart structurally from ordinary LDL. Both carry cholesterol through the bloodstream; the extra protein gives Lp(a) a distinctly different — and more problematic — behavior in artery walls.
Can I lower Lp(a) by changing my diet or exercising more?
Largely no. More than 90% of your Lp(a) level is genetically determined, so lifestyle changes have very limited direct effect on the number itself. Diet and exercise remain extremely valuable for your cardiovascular health more broadly — they simply will not move Lp(a) the way they move LDL.
How do I get tested?
Ask your doctor to add Lp(a) to your next blood draw. It is a standard laboratory test — it just is not ordered by default. Ask for it specifically by name.
Should I worry if my level is elevated?
Take it seriously, but don't panic. Elevated Lp(a) is one risk factor among several. A cardiologist can weigh it alongside your LDL, blood pressure, family history, and lifestyle factors to give you an accurate overall picture.
Is there a medication that targets Lp(a)?
Not a widely approved one yet. However, RNA-based therapies specifically designed to lower Lp(a) are currently in advanced clinical trials and the preliminary data looks promising. For now, the strategy is knowing your number and working aggressively on every other cardiovascular risk factor you can influence.
How is Lp(a) different from LDL?
LDL responds to diet and to statin medications. Lp(a) is set by your genetics, carries the extra apolipoprotein(a) protein that alters its behavior, and is measured separately. They represent two distinct pathways through which cardiovascular risk accumulates — which is precisely why measuring both matters. For informational purposes only — not medical advice. Do not change your diet, exercise, or health routine without first consulting your licensed healthcare professional.
Sources
Nordestgaard BG, et al. (2010). Lipoprotein(a) as a cardiovascular risk factor: current status.Eur Heart J.PMID: 20965889. https://pubmed.ncbi.nlm.nih.gov/20965889/
Kronenberg F, et al. (2022). Lipoprotein(a) in atherosclerotic cardiovascular disease and aortic stenosis: a European Atherosclerosis Society consensus statement.Eur Heart J.PMID: 36036785. https://pubmed.ncbi.nlm.nih.gov/36036785/
Brandts J, Ray KK. (2024). Human Genetics of Lipoprotein(a) and Emerging Therapeutics.Annu Rev Pharmacol Toxicol.PMID: 37506332. https://pubmed.ncbi.nlm.nih.gov/37506332/
Ridker PM, et al. (2024). Inflammation, Cholesterol, Lipoprotein(a), and 30-Year Cardiovascular Outcomes in Women.N Engl J Med.PMID: 39216091. https://pubmed.ncbi.nlm.nih.gov/39216091/
Nordestgaard BG, Langsted A. (2024). Lipoprotein(a) and cardiovascular disease.Lancet.PMID: 39278229. https://pubmed.ncbi.nlm.nih.gov/39278229/
Romani M, et al. (2019). Niacin: an old lipid drug in a new NAD+ dress.J Lipid Res. https://doi.org/10.1194/jlr.s092007
Innes JK, Calder PC. (2021). An Update on Omega-3 Polyunsaturated Fatty Acids and Cardiovascular Health.Nutrients.PMID: 33445534. https://pubmed.ncbi.nlm.nih.gov/33445534/
These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease.
Roger's writing focuses on the science of aging, metabolic health, gut health, immune support, and evidence-based nutrition strategies. He translates peer-reviewed research and supplement industry knowledge into clear, practical guidance for adults who want to better understand how nutrition, lifestyle, and targeted supplementation can support healthy aging in midlife and beyond.
About the author — Roger Braun is the founder of Eternal Springs Bio, a NASM Certified Nutrition Coach, and a wellness entrepreneur with more than 14 years of experience in the dietary supplement industry. He earned his Bachelor's Degree in General Studies from Western Illinois University and has spent his career working with nutrition, supplement, and healthy-aging products.
Roger's writing focuses on the science of aging, metabolic health, gut health, immune support, and evidence-based nutrition strategies. He translates peer-reviewed research and supplement industry knowledge into clear, practical guidance for adults who want to better understand how nutrition, lifestyle, and targeted supplementation can support healthy aging in midlife and beyond.
Based on original ideas, research direction, and editorial review by the author, with AI-assisted drafting support.
This article is for informational purposes only — see the full disclosure below.
This article is for informational purposes only and is not medical advice. Do your own research and talk to your doctor before changing your diet, exercise routine, supplements, or health habits. The Food and Drug Administration has not evaluated these statements. If the above article mentions product(s), please know, These products are not intended to diagnose, treat, cure, or prevent any disease.
